Abstract
Today, immunoassays and several chromatographic methods are in use for drug screening in clinical and forensic toxicology and in doping control. For further proof of the authors’ new metabolite-based liquid chromatography-mass spectrometry (LC-MSn) screening concept, the detectability of drugs of abuse and their metabolites using this screening approach was studied. As previously reported, the corresponding reference library was built up with MS2 and MS3 wideband spectra using a LXQ linear ion trap with electrospray ionization in the positive mode and full scan information-dependent acquisition. In addition to the parent drug spectra recorded in methanolic solution, metabolite spectra were identified after protein precipitation of urine from rats after administration of the corresponding drugs and added to the library. This consists now of data of over 900 parent compounds, including 87 drugs of abuse, and of over 2,300 metabolites and artifacts, among them 436 of drugs of abuse. Recovery, process efficiency, matrix effects, and limits of detection for selected drugs of abuse were determined using spiked human urine, and the resulting data have been acceptable. Using two automatic data evaluation tools (ToxID and SmileMS), the intake of 54 of the studied drugs of abuse could be confirmed in urine samples of drug users after protein precipitation and LC separation. The following drugs classes were covered: stimulants, designer drugs, hallucinogens, (synthetic) cannabinoids, opioids, and selected benzodiazepines. The presented LC-MSn method complements the well-established gas chromatography-mass spectroscopy procedure in the authors’ laboratory.
Similar content being viewed by others
References
Kraemer T, Paul LD (2007) Anal Bioanal Chem 388:1415–1435
Maurer HH (2006) J Mass Spectrom 41:1399–1413
Maurer HH (2009) Anal Bioanal Chem 393:97–107
Peters FT, Martinez-Ramirez JA (2010) Ther Drug Monit 32:532–539
Tenore PL (2010) J Addict Dis 29:436–448
Maurer HH (2007) Anal Bioanal Chem 388:1315–1325
Peters FT (2010) Clin Biochem 44:54–65
Josephs JL, Sanders M (2004) Rapid Commun Mass Spectrom 18:743–759
Sauvage FL, Saint-Marcous F, Duretz B, Deporte D, Lachatre G, Marquet P (2006) Clin Chem 52:1735–1742
Dulaurent S, Moesch C, Marquet P, Gaulier JM, Lachatre G (2010) Anal Bioanal Chem 396:2235–2249
Sturm S, Hammann F, Drewe J, Maurer HH, Scholer A (2010) J Chromatogr B 878:2726–2732
Mueller DM, Duretz B, Espourteille FA, Rentsch KM (2011) Anal Bioanal Chem 400:89–100
Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Anal Bioanal Chem 400:79–88
Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M (2005) Rapid Commun Mass Spectrom 19:1332–1338
Dresen S, Gergov M, Politi L, Halter C, Weinmann W (2009) Anal Bioanal Chem 395:2521–2526
Picard N, Dridi D, Sauvage FL, Boughattas NA, Marquet P (2009) J Sep Sci 32:2209–2217
Sauvage FL, Picard N, Saint-Marcoux F, Gaulier JM, Lachatre G, Marquet P (2009) J Sep Sci 32:3074–3083
Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W (2010) Anal Bioanal Chem 396:2425–2434
Viette V, Guillarme D, Mylonas R, Mauron Y, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL (2011) Clin Biochem 44:32–44
Viette V, Guillarme D, Mylonas R, Mauron Y, Fathi M, Rudaz S, Hochstrasser D, Veuthey JL (2011) Clin Biochem 44:45–53
Gonzalez O, Alonso RM, Ferreiros N, Weinmann W, Zimmermann R, Dresen S (2011) J Chromatogr B Analyt Technol Biomed Life Sci 879:243–252
Decaestecker TN, Vande C Sr, Wallemacq PE, Van Peteghem CH, Defore DL, Van Bocxlaer JF (2004) Anal Chem 76:6365–6373
Pavlic M, Libiseller K, Oberacher H (2006) Anal Bioanal Chem 386:69–82
Lee HK, Ho CS, Iu YP, Lai PS, Shek CC, Lo YC, Klinke HB, Wood M (2009) Anal Chim Acta 649:80–90
Broecker S, Herre S, Wust B, Zweigenbaum J, Pragst F (2011) Anal Bioanal Chem 400:101–117
Wohlfarth A, Weinmann W, Dresen S (2010) Anal Bioanal Chem 396:2403–2414
Ristimaa J, Gergov M, Pelander A, Halmesmaki E, Ojanpera I (2010) Anal Bioanal Chem 398:925–935
Kala SV, Harris SE, Freijo TD, Gerlich S (2008) J Anal Toxicol 32:605–611
Feng J, Wang L, Dai I, Harmon T, Bernert JT (2007) J Anal Toxicol 31:359–368
Duxbury K, Romagnoli C, Anderson M, Watts R, Waite G (2010) Ann Clin Biochem 47:415–422
Bouzas NF, Dresen S, Munz B, Weinmann W (2009) Anal Bioanal Chem 395:2499–2507
Baker DR, Kasprzyk-Hordern B (2011) J Chromatogr A 1218:1620–1631
Bjork MK, Nielsen MK, Markussen LO, Klinke HB, Linnet K (2010) Anal Bioanal Chem 396:2393–2401
Baselt RC (2009) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Foster City
Remane D, Meyer MR, Wissenbach DK, Maurer HH (2010) Rapid Commun Mass Spectrom 24:3103–3108
Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019–3030
Hopley C, Bristow T, Lubben A, Simpson A, Bull E, Klagkou K, Herniman J, Langley J (2008) Rapid Commun Mass Spectrom 22:1779–1786
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Philipp AA, Wissenbach DK, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH (2009) J Mass Spectrom 44:1249–1261
Philipp AA, Wissenbach DK, Weber AA, Zapp J, Zoerntlein SW, Klein ON, Kanogsunthornrat J, Maurer HH (2010) Anal Bioanal Chem 396:2379–2391
Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2010) J Mass Spectrom 45:1344–1357
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Philipp AA, Wissenbach DK, Weber AA, Zapp J, Maurer HH (2011) Anal Bioanal Chem 399:2747–2753
Meyer MR, Maurer HH (2010) Curr Drug Metab 11:468–482
Paul LD, Musshoff F, Aebi B, Auwaerter V, Kraemer T, Peters FT, Skopp G, Aderjan R, Herbold M, Schmitt G, Thieme D, Toennes S (2009) Toxichem Krimtech 76:142–176 (http://www.gtfch.org/cms/index.php/guidelines)
Li AC, Gohdes MA, Shou WZ (2007) Rapid Commun Mass Spectrom 21:1421–1430
Rivier L (2003) Anal Chim Acta 492:69–82
Balikova M (2005) Forensic Sci Int 153:85–91
Beyer J, Ehlers D, Maurer HH (2006) Ther Drug Monit 28:568–575
Staack RF, Fritschi G, Maurer HH (2002) J Chromatogr B Analyt Technol Biomed Life Sci 773:35–46
Staack RF, Maurer HH (2003) J Anal Toxicol 27:560–568
Acknowledgements
The authors thank Golo M. Meyer, Andrea E. Schwaninger, Carsten Schröder, and Gabi Ulrich, as well as Kornelia Weidemann and Edeltraud Thiry (ThermoFisher Scientific Instruments, Dreieich, Germany), and Pierre-Alain Binz, Nicolas Budin, Yann Mauron, and Roman Mylonas (GeneBio, Geneva, Switzerland) for their support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 451 kb)
Rights and permissions
About this article
Cite this article
Wissenbach, D.K., Meyer, M.R., Remane, D. et al. Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept. Anal Bioanal Chem 400, 3481–3489 (2011). https://doi.org/10.1007/s00216-011-5032-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5032-1